 <h1>Mestinon Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>pyridostigmine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about pyridostigmine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Mestinon.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pyridostigmine: oral conventional 30-mg tablets for military use, oral conventional 60-mg tablets and extended-release tablets, oral oral solution, parenteral injection</i></p><h3>Warning</h3><p><ul>
Military Use for Soman Poisoning Prophylaxis
<li>
Use of pyridostigmine alone is <i>not</i> protective against soman effects.&lt;sup&gt;111&lt;/sup&gt;  Efficacy depends on rapid use of nerve agent antidotes (i.e., atropine and pralidoxime) following nerve agent exposure.&lt;sup&gt;111&lt;/sup&gt;</li></ul></p><ul>
Military Use for Soman Poisoning Prophylaxis
<li>
Use of pyridostigmine alone is <i>not</i> protective against soman effects.&lt;sup&gt;111&lt;/sup&gt;  Efficacy depends on rapid use of nerve agent antidotes (i.e., atropine and pralidoxime) following nerve agent exposure.&lt;sup&gt;111&lt;/sup&gt;</li></ul><p>
<li>
Protective garments (e.g., masks, hoods, overgarments) specifically designed for protection from chemical nerve agents are the primary means of protection against nerve agent exposure; do not rely solely on pretreatment with pyridostigmine, atropine, and pralidoxime to provide complete protection.&lt;sup&gt;111&lt;/sup&gt;</li></p><p>
<li>
Do not administer pyridostigmine <i>after</i> soman exposure.&lt;sup&gt;111&lt;/sup&gt;  Discontinue at first sign of nerve agent poisoning; may exacerbate effects of a sublethal exposure.&lt;sup&gt;111&lt;/sup&gt;</li></p><p></p><p><ul>
Experience of Health Care Personnel
<li>
Pyridostigmine should be administered by IV injection only by adequately trained individuals familiar with the drug’s actions, characteristics, and risks.&lt;sup&gt;124&lt;/sup&gt;</li></ul></p><ul>
Experience of Health Care Personnel
<li>
Pyridostigmine should be administered by IV injection only by adequately trained individuals familiar with the drug’s actions, characteristics, and risks.&lt;sup&gt;124&lt;/sup&gt;</li></ul><p></p><p>Side effects include:</p><p>Diarrhea,  abdominal pain or cramps,   dysmenorrhea,  increased flatus,  nausea,  urinary urgency and frequency. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pyridostigmine: injectable solution, oral syrup, oral tablet, oral tablet extended release</i></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Nausea, vomiting, diarrhea, abdominal cramps, GI hypermotility, salivary hypersecretion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Increased bronchial secretion combined with bronchoconstriction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Muscle weakness, fasciculation, tremors, muscle cramps, muscle hypotonia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Miosis, increased lacrimation, accommodation disorders<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Rash, hyperhidrosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Arrhythmia (including bradycardia, tachycardia, AV block), syncope, hypotension<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Urinary urgency<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Regonol (pyridostigmine)." Organon, West Orange, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Mestinon (pyridostigmine)." ICN Pharmaceuticals Inc, Cost Mesa, CA. </p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Mestinon (pyridostigmine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>23 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: cholinergic muscle stimulants</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Mestinon Timespan</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Dysautonomia</li>
<li>Myasthenia Gravis</li>
<li>Reversal of Nondepolarizing Muscle Relaxants</li>
<li>Nerve Agent Pretreatment</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>